abnormal cannabidiol has been researched along with n-arachidonylglycine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradshaw, HB; Dunn, E; McHugh, D; Page, J | 1 |
| Drabczyńska, A; Kieć-Kononowicz, K; Mahardhika, AB; Müller, CE; Schoeder, CT | 1 |
2 other study(ies) available for abnormal cannabidiol and n-arachidonylglycine
| Article | Year |
|---|---|
Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells.
Topics: Arachidonic Acids; Cell Line, Tumor; Cell Movement; Dronabinol; Endometrium; Female; Glycine; HEK293 Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptors, G-Protein-Coupled; RNA, Messenger; Transfection | 2012 |
Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18.
Topics: | 2020 |